Li, Ang <br/><br/>
Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis.  [electronic resource] 

 -  Thrombosis research  01 2019 
 - 158-163 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Systematic Review 
<br/><br/><label>ISSN: </label>1879-2472 
<br/><br/><label>Standard No.: </label>10.1016/j.thromres.2018.02.144  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Anticoagulants--administration & dosage<br/>Hemorrhage--chemically induced<br/>Heparin, Low-Molecular-Weight--administration & dosage<br/>Humans<br/>Neoplasms--complications<br/>Secondary Prevention<br/>Thrombosis--drug therapy<br/>Venous Thromboembolism--drug therapy